SuperworthPhio Pharmaceuticals shares outstanding PHIO
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2025
- 4.8M
- On a year earlier
- +839.8%
- more shares
Phio Pharmaceuticals had 4.8M diluted shares outstanding on average in Q2 FY25, the quarter to Jun 30, 2025.
That is 839.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 1.1M | +241% |
| FY2023 | 333.2K | +163% |
| FY2022 | 126.6K | +1% |
| FY2021 | 125.3K | +134% |
| FY2020 | 53.7K | +921% |
| FY2019 | 5.3K | +83% |
| FY2018 | 2.9K | +618% |
| FY2017 | 401 | +224% |
| FY2016 | 123 | +12% |
| FY2015 | 110 | +208% |
| FY2014 | 36 | +82% |
| FY2013 | 20 | +121% |
| FY2012 | 9 | +10316% |
| FY2011 | 0 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY25 | 4.8M | +840% | |
| Q1 FY25 | 4.3M | +746% | |
| Q4 FY24 | 1.1M | +241% | |
| Q3 FY24 | 990K | +265% | |
| Q2 FY24 | 510.2K | +166% | |
| Q1 FY24 | 508.9K | +301% | |
| Q4 FY23 | 333.2K | +163% | |
| Q3 FY23 | 271.1K | +114% | |
| Q2 FY23 | 192.1K | −100% | |
| Q1 FY23 | 126.9K | +1% | |
| Q4 FY22 | 126.6K | +1% | |
| Q3 FY22 | 126.5K | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Phio Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.